These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10680752)

  • 41. A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions.
    Locke IC; Leaker B; Cambridge G
    Clin Exp Immunol; 1999 Feb; 115(2):369-76. PubMed ID: 9933467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burek CL; Hu Q; Kuppers RC; Lee B; Prendergast RA
    Cell Immunol; 1992 May; 141(2):496-507. PubMed ID: 1576659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
    Liang B; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 2000 Sep; 165(6):3436-43. PubMed ID: 10975864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimyeloperoxidase antibodies in patients with extracapillary glomerulonephritis.
    Nässberger L; Sjöholm AG; Thysell H
    Nephron; 1990; 56(2):152-6. PubMed ID: 2173810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass.
    Cambridge G; Williams M; Leaker B; Corbett M; Smith CR
    Ann Rheum Dis; 1994 Jan; 53(1):24-9. PubMed ID: 8311550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testing on formalin-fixed neutrophils is less sensitive and specific for small vessel vasculitis, and less sensitive for MPO-ANCA, than most ELISAs.
    Pollock W; Trevisin M; Savige J;
    J Immunol Methods; 2008 Dec; 339(2):141-5. PubMed ID: 18823991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic basis of tissue specificity of vasculitis in MRL/lpr mice.
    Yamada A; Miyazaki T; Lu LM; Ono M; Ito MR; Terada M; Mori S; Hata K; Nozaki Y; Nakatsuru S; Nakamura Y; Onji M; Nose M
    Arthritis Rheum; 2003 May; 48(5):1445-51. PubMed ID: 12746919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
    Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
    J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Burns WH; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):246-50. PubMed ID: 8550330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
    Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
    J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.
    Zhang X; Dong Y; Zeng X; Li Y; Tang F
    Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies.
    Guilpain P; Servettaz A; Batteux F; Guillevin L; Mouthon L
    Autoimmun Rev; 2008 Jun; 7(6):421-5. PubMed ID: 18558355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody.
    Jabs DA; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2718-22. PubMed ID: 1680111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
    Gross WL; Csernok E; Helmchen U
    APMIS; 1995 Feb; 103(2):81-97. PubMed ID: 7748541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High mobility group box-1 contributes to anti-myeloperoxidase antibody-induced glomerular endothelial cell injury through a moesin-dependent route.
    Deng H; Wang C; Chang DY; Hu N; Chen M; Zhao MH
    Arthritis Res Ther; 2017 Jun; 19(1):125. PubMed ID: 28587670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The characteristics of hematopoietic stem cells from autoimmune-prone mice and the role of neural cell adhesion molecules in abnormal proliferation of these cells in MRL/lpr mice.
    Wang X; Hisha H; Cui W; Song C; Mizokami T; Okazaki S; Li Q; Feng W; Kato J; Jiang S; Fan H; Ikehara S
    Haematologica; 2007 Mar; 92(3):300-7. PubMed ID: 17339178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.